Craft

Arog Pharmaceuticals

Arog Pharmaceuticals Summary

Company Summary

Overview
Arog Pharmaceuticals is a biopharmaceutical company dedicated to improving the lives of cancer patients by developing crenolanib in indications with high unmet need. Crenolanib is an orally administered, highly potent and selective, mutation-resistant pan-FLT3 inhibitor.
Type
Private
Status
Active
Founded
2010
HQ
Plano, TX, US | view all locations
Website
https://arogpharma.com/
Cybersecurity rating
Sectors

Key People

  • Taizoon Khokhar

    Taizoon Khokhar, Chief Operating Officer

Operating MetricsView all

Patients Reached

400

Q3, 2018

LocationsView all

1 location detected

  • Plano, TX HQ

    United States

    2700 W Plano Pkwy

Arog Pharmaceuticals Financials

Summary Financials

Net income (Q2, 2018)
($3.7M)
Cash (Q2, 2018)
$887.0K
EBIT (Q2, 2018)
($3.7M)

Footer menu